Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells

Clinical Immunology

Volumn 138, Issue 1, 2011, Pages 33-40

  Liang, YanMei ^a   Hasturk, Hatice ^b   Elliot, Jennifer ^a   Noronha, Ansu ^c   Liu, Xiuping ^a   Wetzler, Lee M ^a   Massari, Paola ^a   Kantarci, Alpdogan ^b   Winter, Harland S ^d   Farraye, Francis A ^c   Ganley Leal, Lisa M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adjuvants; B cells; Human; Mucosal immunity; Toll like receptor 2

Indexed keywords

CCL25 CHEMOKINE; CCL28 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR9; HOMING RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN J CHAIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL HOMING; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; MUCOSA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CHEMOKINES, CC; CHEMOTAXIS; CROHN DISEASE; DENTAL PROPHYLAXIS; FEMALE; GENE EXPRESSION; HUMANS; ILEUM; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN J-CHAINS; IMMUNOGLOBULIN M; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PALATINE TONSIL; PORINS; RECEPTORS, CCR; RECEPTORS, CCR10; RECEPTORS, LYMPHOCYTE HOMING; TOLL-LIKE RECEPTOR 2; YOUNG ADULT;

EID: 78651389295     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.09.003     Document Type: Article

References (30)

1. Malik B., Goyal A.K., Mangal S., Zakir F., Vyas S.P. Implication of gut immunology in the design of oral vaccines. Curr. Mol. Med. 2010, 10(1):47-70.
2. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 2005, 11(4 Suppl):S45-S53.
3. Svennerholm A.M., Steele D. Microbial-gut interactions in health and disease. Progress in enteric vaccine development. Best Pract. Res. Clin. Gastroenterol. 2004, 18(2):421-445.
4. Bines J. Intussusception and rotavirus vaccines. Vaccine 2006, 24(18):3772-3776.
5. Lynch M., Shieh W.J., Bresee J.S., et al. Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism. Pediatrics 2006, 117(5):e827-e832.
6. Svennerholm A.M., Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev. Vaccines 2008, 7(6):795-804.
7. MacDonald T.T. The mucosal immune system. Parasite Immunol. 2003, 25(5):235-246.
8. Johansen F.E., Baekkevold E.S., Carlsen H.S., Farstad I.N., Soler D., Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 2005, 106(2):593-600.
9. Sundstrom P., Lundin S.B., Nilsson L.A., Quiding-Jarbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur. J. Immunol. 2008, 38(12):3327-3338.
10. Jagannathan M., Hasturk H., Liang Y., et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J. Immunol. 2009, 183(11):7461-7470.
11. Noronha A.M., Liang Y., Hetzel J.T., et al. Hyperactivated B cells in human inflammatory bowel disease. J. Leukoc. Biol. 2009, 86(4):1007-1016.
12. Ganley-Leal L.M., Liu X., Wetzler L.M. Toll-like receptor 2-mediated human B cell differentiation. Clin. Immunol. 2006, 120(3):272-284.
13. Bekeredjian-Ding I., Inamura S., Giese T., Moll H., Endres S., Sing A., Zahringer U., Hartmann G. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J. Immunol. 2007, 178(5):2803-2812.
14. Massari P., King C.A., MacLeod H., Wetzler L.M. Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Expr. Purif. 2005, 44(2):136-146.
15. Pabst O., Ohl L., Wendland M., Wurbel M.A., Kremmer E., Malissen B., Forster R. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 2004, 199(3):411-416.
16. Kunkel E.J., Kim C.H., Lazarus N.H., Vierra M.A., Soler D., Bowman E.P., Butcher E.C. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 2003, 111(7):1001-1010.
17. Massari P., Visintin A., Gunawardana J., Halmen K.A., King C.A., Golenbock D.T., Wetzler L.M. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 2006, 176(4):2373-2380.
18. Latz E., Franko J., Golenbock D.T., Schreiber J.R. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J. Immunol. 2004, 172(4):2431-2438.
19. Lo C.G., Lu T.T., Cyster J.G. Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 2003, 197(3):353-361.
20. Ansel K.M., Ngo V.N., Hyman P.L., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406(6793):309-314.
21. Brandtzaeg P., Johansen F.E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 2005, 206:32-63.
22. Morrison S.L., Koshland M.E. Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure). Proc. Natl. Acad. Sci. U. S. A. 1972, 69(1):124-128.
23. Lockhart P.B., Brennan M.T., Sasser H.C., Fox P.C., Paster B.J., Bahrani-Mougeot F.K. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008, 117(24):3118-3125.
24. Brayden D.J., Jepson M.A., Baird A.W. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov. Today 2005, 10(17):1145-1157.
25. Corr S.C., Gahan C.C., Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol. Med. Microbiol. 2008, 52(1):2-12.
26. Mestecky J., Russell M.W. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol. Lett. 2009, 124(2):57-62.
27. Wijburg O.L., Uren T.K., Simpfendorfer K., Johansen F.E., Brandtzaeg P., Strugnell R.A. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J. Exp. Med. 2006, 203(1):21-26.
28. Shin H., Zhang Y., Jagannathan M., et al. B cells from periodontal disease patients express surface Toll-like receptor 4. J. Leukoc. Biol. 2009, 85(4):648-655.
29. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L., Carroll M.C., Rajewsky K. B cell receptor signal strength determines B cell fate. Nat. Immunol. 2004, 5(3):317-327.
30. Suzuki K., Fagarasan S. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol. 2008, 29(11):523-531.